Sexual health

How HIV Treatment Works Now

Save

HIV treatment today looks nothing like it did decades ago, but the underlying goal is unchanged: suppress the virus to undetectable and keep it there. This piece covers what antiretroviral therapy actually does, what undetectable and U=U mean in practice, how ongoing treatment differs from PrEP and PEP, and what confidentiality looks like around a diagnosis.

Last updated: July 2026History

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does HIV treatment actually do?

Antiretroviral therapy does not remove HIV from the body — it stops the virus from multiplying, and taken consistently, it lowers the amount of virus in the blood until standard tests can no longer detect it. That state is called an undetectable viral load, and it is the entire goal of modern HIV treatment 1.

Undetectable does not mean cured — the virus is still present, and treatment has to continue on an ongoing basis to keep it suppressed. Stopping treatment allows the virus to rebound, usually within weeks, which is why HIV treatment today is understood as a lifelong commitment rather than a fixed course.

Getting diagnosed: how testing leads to treatment

Treatment starts with a diagnosis, and HIV testing today is more sensitive and faster than it used to be. National guidance recommends that everyone between ages 13 and 64 be tested for HIV at least once, regardless of perceived risk, since the goal is finding infections before symptoms ever appear 2.

Different HIV tests become accurate at different points after a possible exposure. A nucleic acid test can detect the virus roughly 10 to 33 days after exposure, a lab antigen/antibody test around 18 to 45 days, and a rapid antibody test around 23 to 90 days — understanding hiv testing window timing matters for anyone testing shortly after a specific exposure rather than as part of routine screening 3.

What 'undetectable' means, and why it matters beyond the lab report

A person with HIV who takes antiretroviral therapy and maintains an undetectable viral load has effectively zero risk of sexually transmitting HIV to a partner. That finding, known as U=U (undetectable equals untransmittable), is one of the most consequential facts in modern HIV care 1.

U=U changed the emotional weight of a diagnosis for many people living with hiv, because it replaced an open-ended fear of transmitting the virus with a specific, achievable target: reach and maintain an undetectable viral load, and the transmission risk to sexual partners is effectively eliminated. It does not, on its own, protect against other STIs, which is why regular sexual health screening remains part of care even for someone who is undetectable.

Staying suppressed: what ongoing treatment actually involves

Reaching an undetectable viral load is the first milestone; staying there is the ongoing work of treatment. That means taking antiretroviral therapy consistently, as prescribed, and attending regular follow-up visits where a clinician checks viral load and overall health rather than symptoms alone 1.

Missing doses repeatedly is what allows the virus to rebound and, over time, can allow treatment-resistant hiv to develop — a version of the virus less responsive to the medications being used, which then requires a change in regimen. Consistency, more than any single feature of a regimen, is what keeps treatment working long-term, which is part of why clinicians spend real time on adherence, not just on which medications are prescribed.

The difference between PEP and ongoing HIV treatment

PEP (post-exposure prophylaxis) and ongoing treatment for someone already living with HIV are easy to confuse but serve different purposes. PEP is a short emergency course started within a pep window of no more than 72 hours after a specific possible exposure, meant to prevent an infection from taking hold in someone who is HIV-negative 4.

PEP runs for a defined 28-day course and is not a substitute for ongoing treatment. Someone who is later diagnosed with HIV moves into the same ongoing antiretroviral therapy described throughout this piece, aimed at long-term viral suppression rather than a one-time emergency response 4.

What about a partner who doesn't have HIV?

For a sexual partner who does not have HIV, there are two additional layers of protection beyond U=U: PrEP taken consistently before exposure, and PEP taken shortly after one. PrEP reduces the risk of getting HIV from sex by about 99% when taken as prescribed, and is available as a daily pill or a longer-acting injectable option 5.

None of this replaces U=U for a partner who is undetectable — the two protections are complementary, not competing, and a couple where one partner has HIV and is undetectable while the other uses PrEP is, practically speaking, doubly protected against sexual transmission of HIV specifically. PrEP does not protect against other STIs, which is a separate reason routine sexual health screening stays part of the picture for both partners.

Confidentiality, disclosure, and the practical side of treatment

HIV status carries real legal and privacy considerations alongside the medical ones. Confidential testing means a result is tied to a person's name but reported to health departments with identifying details removed before reaching federal surveillance data, which is different from anonymous testing that never attaches a name at all 6.

Separately, many states have their own sti disclosure law that governs whether and how someone living with HIV is required to tell a sexual partner about their status, and those laws vary significantly by state and have not always kept pace with what U=U means for actual transmission risk. That legal landscape is a distinct question from the medical one, and worth understanding on its own terms rather than assuming it matches the science.

Untreated HIV, and the longer-term outlook

Everything above assumes treatment is underway; the picture looks meaningfully different without it. What actually happens over time when HIV goes untreated — the stages of untreated hiv, from initial infection through advanced immune damage — is a separate, fuller topic worth reading on its own terms rather than summarizing here.

The same is true of the longer-term outlook: the question of living a full life with hiv on treatment is significant enough, and different enough from the pre-treatment era, to deserve its own dedicated look rather than a brief mention in a piece about how treatment itself works.

Common questions

No. Antiretroviral therapy suppresses the virus to an undetectable level but does not eliminate it from the body. Treatment has to continue on an ongoing basis to keep the virus suppressed; stopping it allows the virus to rebound, usually within weeks.

It means a routine blood test cannot find measurable virus in the blood, because treatment has suppressed it below the test's detection threshold. It does not mean the virus is gone — it means treatment is working, and sustained over time, it also means effectively no risk of sexually transmitting HIV to a partner.

Regular follow-up visits check viral load and overall health, though the exact schedule depends on how long someone has been on treatment and how stable their results have been. Monitoring tends to be more frequent soon after starting treatment than once viral suppression is well established.

If viral load is undetectable and stays that way, the risk of sexually transmitting HIV to a partner is effectively zero — this is what U=U, undetectable equals untransmittable, means. That protection depends on maintaining viral suppression, not on having reached undetectable status once in the past.

Missing doses gives the virus room to rebound and, over time, can allow it to develop resistance to the medications being used. Consistency in taking treatment as prescribed is one of the most important factors in keeping a regimen working long-term.

Yes. PrEP and PEP are for people who do not have HIV and are trying to prevent getting it, taken before or shortly after a possible exposure. Antiretroviral therapy is for someone already living with HIV, taken on an ongoing basis to suppress a virus that is already present.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to seek care related to HIV treatment

  • —Missing several days of treatment in a row, especially after a period of being undetectable
  • —New, unexplained fevers, night sweats, or weight loss while on treatment
  • —Signs of a severe allergic reaction to a medication: widespread rash, facial or throat swelling, difficulty breathing
  • —Any new or worsening symptom that feels different from a typical side effect

Facial or throat swelling, difficulty breathing, or a widespread rash after starting a new medication needs immediate emergency care — call 911 or go to the nearest ER.

This explains how HIV treatment generally works; it is educational information, not medical advice. Treatment decisions, monitoring schedules, and any regimen changes belong with the clinician managing an individual's care.

Did this answer your question?

References

  1. 1.Centers for Disease Control and Prevention (2024). Undetectable = Untransmittable. CDC Global HIV and TB. linkSupports that antiretroviral therapy works by lowering viral load to an undetectable level, that this state must be maintained through ongoing treatment, and that a person with HIV who maintains an undetectable viral load has effectively zero risk of sexually transmitting HIV to a partner (U=U).
  2. 2.Centers for Disease Control and Prevention (2024). Getting Tested for HIV. CDC (cdc.gov/hiv). linkSupports that CDC recommends everyone aged 13-64 test for HIV at least once regardless of perceived risk, and that multiple test types exist, including self-testing options.
  3. 3.Centers for Disease Control and Prevention (2024). Clinical Testing Guidance for HIV. CDC HIV Nexus. linkSupports HIV test window periods by test type: NAT approximately 10-33 days after exposure, lab antigen/antibody approximately 18-45 days, and rapid antibody tests approximately 23-90 days.
  4. 4.Centers for Disease Control and Prevention (2024). Clinical Guidance for PEP. CDC HIV Nexus. linkSupports that HIV PEP must be started as soon as possible and within 72 hours of exposure, is taken for a 28-day course, and is for emergency/one-time exposures rather than ongoing treatment of an existing infection.
  5. 5.Centers for Disease Control and Prevention (2024). Clinical Guidance for PrEP. CDC HIV Nexus. linkSupports that PrEP, taken as prescribed, reduces the risk of getting HIV from sex by about 99%, and that oral and injectable (cabotegravir) PrEP options exist; used here to describe protection available to an HIV-negative partner alongside U=U.
  6. 6.HIV.gov (U.S. Department of Health and Human Services) (2024). Limits on Confidentiality. HIV.gov. link ✓Supports the distinction between confidential HIV testing (name attached, positive results reported to health departments with identifiers removed before reaching CDC) and anonymous testing, and describes the general limits on confidentiality for HIV status.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library